Marc Iskowitz

Marc Iskowitz

Marc Iskowitz has covered healthcare marketing, advertising and media for MM&M since 2005, but has followed the medical beat in a variety of roles since ‘96 or so. He has also moderated judging panels for the MM&M Awards. If you have story ideas, tips or criticism, e-mail me. And feel free to follow me on Twitter.

Most Recent Articles by Marc Iskowitz

Five-Figure Salaries. Big Hair. Pharma, 1987

Five-Figure Salaries. Big Hair. Pharma, 1987

When the Career and Salary Survey made its debut, in 1987, Eli Lilly's Prozac led the list of mass-market drug launches and AIDS therapy had taken a big step forward with the approval of GlaxoSmithKline's AZT, a year earlier.

With Gender Issues, Details Matter

With Gender Issues, Details Matter

Were we trying to celebrate these women for having made hard-won progress in gender parity while also perpetuating a stereotype about them?

Five things for pharma marketers to know: Wednesday, July 20, 2016

Five things for pharma marketers to know: Wednesday, July 20, 2016

Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger

Can pharma movement campaigns flourish on both sides of the Atlantic?

Can pharma movement campaigns flourish on both sides of the Atlantic?

Executives attending Cannes Lions Health weigh in on the imbalance seen in the U.S. between branded and unbranded drug ads.

Revenues surge as agencies adapt to health-tech, payer trends

Healthcare agencies focus on freeing pharma brands from their collaboration cocoons to work with health tech companies, while squaring away access concerns.

More Articles by Marc Iskowitz

OPINION

Email Newsletters